IMC Chicago’s Elevance Health ELV Stock Holding History

IMC Chicago’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-20,451	Closed	-$6.91M	–	4153
2025 Q3	$6.61M	Buy	+20,451	New	+$6.36M	﹤0.01%	1396

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

IMC Chicago's ELV Position: Q4 2025 in Review

IMC Chicago sold out of Elevance Health (ELV) in Q4 2025, closing a stake of 20,451 shares — an estimated $6.91M sold.

IMC Chicago first reported a position in ELV in Q3 2025 and held it in 1 quarter. The position peaked at $6.61M in Q3 2025. 1,553 funds tracked by Wall St. Rank hold ELV as of Q4 2025.

IMC Chicago reported no remaining Elevance Health position as of Q4 2025 after selling out during the quarter.
IMC Chicago sold 20,451 Elevance Health shares in Q4 2025, an estimated $6.91M.
IMC Chicago first reported a position in Elevance Health in Q3 2025 and held it in 1 quarter.
IMC Chicago's Elevance Health position peaked at $6.61M in Q3 2025.
1,553 funds tracked by Wall St. Rank held Elevance Health as of Q4 2025.

Based on IMC Chicago's 13F filing for Q4 2025, filed 29 Jan 2026.